---
figid: PMC10532491__jfb-14-00466-g002
pmcid: PMC10532491
image_filename: jfb-14-00466-g002.jpg
figure_link: /pmc/articles/PMC10532491/figure/jfb-14-00466-f002/
number: Figure 2
figure_title: ''
caption: 'EGF signaling pathway in the proliferation of NSCLC. Abbreviations: EGF,
  epidermal growth factor; TGFÎ±, Transforming growth factor alpha; HGF, Hepatocyte
  growth factor; ERBB2, tyrosine-protein kinase erbB-2 receptor; EGFR, epidermal growth
  factor receptor; MET, proto-oncogene tyrosine-protein kinase Met; Grb2, growth factor
  receptor-bound protein 2; SOS, son of sevenless; Ras, GTPase HRas; Raf, A-Raf proto-oncogene
  serine/threonine-protein kinase; MEK, mitogen-activated protein kinase 1; ERK, mitogen-activated
  protein kinase 1/3; cyclidinD1, G1/S-specific cyclin-D1; KIF5B-RET, kinesin family
  member 5; EML4-ALK, anaplastic lymphoma kinase; K-ras, GTPase KRas.'
article_title: Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer.
citation: Andreea Crintea, et al. J Funct Biomater. 2023 Sep;14(9):466.
year: '2023'

doi: 10.3390/jfb14090466
journal_title: Journal of Functional Biomaterials
journal_nlm_ta: J Funct Biomater
publisher_name: MDPI

keywords:
- lung cancer
- EGFR
- non-small cell lung cancer
- nanotherapy

---
